Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
33 current organizations shown on this profile
Board positions
33 supported by public sources, 0 supplied by the profile owner
Committee roles
6Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Retired CFO of Stryker Corporation (2013-2016). Spent 15 years at Dentsply International in leadership positions including CFO. Started career at Donnelly Corporation in multiple financial management roles. Brings over 40 years of business, financial, and executive management experience in MedTech industry.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Director

Medtronic (NYSE: MDT)

Jan 1, 2025 – Present

Independence: Independent

Source effective: 2025-08-25 · Observed: 2026-03-25T05:14:00.713+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies

Structured records are unavailable. This does not establish that no records exist.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

Medtronic

2025-01-01 · current

Confirmed by public sourceView source

Director

Anika Therapeutics, Inc.

2024-01-01 · current

Confirmed by public sourceView source

Director

AVIENT CORP

2015-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

Anika Therapeutics, Inc.

Open Anika Therapeutics, Inc. profile →

Director at Anika Therapeutics, Inc.

2024-01-01 → End not stated

current · source reported

Observed: 2026-09-24

Anika Therapeutics…Anika Therapeutics, Inc.AVIENT CORPAVIENT CORPMedtronicMedtronicWilliam R. Jellison

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingAVNT DEF 14A director slateSupports Board role, Committee assignments, Executive company, Executive title.Open sourceSource 2 · Sec FilingMDT DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Cybersecurity experience, Technology background.Open sourceSource 3 · Sec FilingANIK DEF 14A director slateSupports Board role, Committee assignments.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:william-r-jellison
Record version
public-0

Published evidence records

9 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. AVNT DEF 14A director slate

    sec filing · Source published: Mar 27, 2026 · Retrieved: May 15, 2026

    Supports 4 claims
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Audit, Governance and Corporate Responsibility · Claim reviewed: May 15, 2026
    • Executive company: Executive at Astor Place Holdings · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Senior Advisor · Claim reviewed: May 15, 2026

  2. Open source

    sec proxy · Source published: Mar 27, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at AVIENT CORP · Claim reviewed: May 15, 2026

  3. MDT DEF 14A director slate

    sec filing · Source published: Aug 25, 2025 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Growth, Operations · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  4. Open source

    sec proxy · Source published: Aug 25, 2025 · Retrieved: Mar 25, 2026

    Supports 1 claim
    • Professional Role: Director at Medtronic · Claim reviewed: May 15, 2026

  5. ANIK DEF 14A director slate

    sec filing · Source published: Apr 28, 2025 · Retrieved: May 15, 2026

    Supports 2 claims
    • Board role: Board role: Director · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Audit Committee, Capital Allocation Committee · Claim reviewed: May 15, 2026

  6. Open source

    sec proxy · Source published: Apr 28, 2025 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at Anika Therapeutics, Inc. · Claim reviewed: May 15, 2026

  7. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Medtronic · Claim reviewed: May 15, 2026

  8. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Anika Therapeutics, Inc. · Claim reviewed: May 15, 2026

  9. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of AVIENT CORP · Claim reviewed: May 15, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Board membership · Source reportedServes on the board of Anika Therapeutics, Inc.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · Source reportedServes on the board of AVIENT CORP1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · Source reportedServes on the board of Medtronic1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board role · CorroboratedBoard role: DirectorSupported by 3 public records3 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Audit Committee, Capital Allocation Committee1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Audit, Governance and Corporate Responsibility1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Committee assignments · Source reportedCommittee assignments: Growth, Operations1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive company · Source reportedExecutive at Astor Place Holdings1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Executive title · Source reportedExecutive title: Senior Advisor1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Technology background · Source reportedTechnology background: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

View all sources9 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments · Executive company · Executive title

  2. https://www.sec.gov/Archives/edgar/data/1122976/000162828026021576/avnt-20260326.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at AVIENT CORP (NYSE: AVNT)

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Cybersecurity experience · Technology background

  4. https://www.sec.gov/Archives/edgar/data/0001613103/000161310325000151/mdt-20250825.htm

    Sec Proxy · Tier not stated · Reviewed Mar 25, 2026

    Supports: Director at Medtronic (NYSE: MDT)

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  6. https://www.sec.gov/Archives/edgar/data/898437/000114036125016082/edge20045980x1_def14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at Anika Therapeutics, Inc. (NASDAQ: ANIK)

  7. https://www.sec.gov/Archives/edgar/data/0001613103/000161310325000151/mdt-20250825.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  8. https://www.sec.gov/Archives/edgar/data/898437/000114036125016082/edge20045980x1_def14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  9. https://www.sec.gov/Archives/edgar/data/1122976/000162828026021576/avnt-20260326.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership